Advanced Solid Tumors with AKT1 E17K Mutation
Conditions
Interventions
None listed
Sponsors
Alterome Therapeutics Inc.
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Countries
France, Spain
Outcome results
None listed